Autoimmunity Reviews
短名 | Autoimmun. Rev. |
Journal Impact | 9.21 |
国际分区 | IMMUNOLOGY(Q1) |
期刊索引 | SCI Q1中科院 1 区 |
ISSN | 1568-9972, 1873-0183 |
h-index | 152 |
国内分区 | 医学(1区)医学免疫学(2区) |
Top期刊 | 是 |
AUTOIMMUNITY REVIEWS 将发布由该领域的一流专家撰写的关于自身免疫不同主题的最新、结构化的评论。文章将包括演示性插图和表格,并且都将带有“带回家”的信息。文章将主要由主编根据国际编辑委员会的建议邀请,并将涵盖自身免疫学的所有领域,桥接基础科学与临床科学之间的差距。基础科学的贡献将包括关于疾病的病理生理学和机制以及基因组学和蛋白质组学的贡献;临床贡献将集中在疾病、新疗法和临床关联上。
期刊主页投稿网址涉及主题 | 医学生物内科学免疫学病理遗传学疾病抗体免疫系统化学生物化学心理学精神科外科自身免疫内分泌学自身抗体 |
出版信息 | 出版商: Elsevier B.V.,出版周期: Bimonthly,期刊类型: journal |
基本数据 | 创刊年份: 2002,原创研究文献占比: 28.68%,自引率:4.30%, Gold OA占比: 30.27% |
平均审稿周期 | 网友分享经验:一般,3-8周 |
平均录用比例 | 网友分享经验:较难 |
期刊引文格式
这些示例是对学术期刊文章的引用,以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章,因此这些字段是可选的。有些电子期刊不提供页面范围,而是列出文章标识符。在这种情况下,使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用,以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
Global burden and cross-country inequalities in six major immune-mediated inflammatory diseases from 1990 to 2021: A systemic analysis of the Global Burden of Disease Study 2021
2024-9-11
Targeting ferroptosis in autoimmune diseases: Mechanisms and therapeutic prospects
2024-9-1
Treatment strategies for Spondyloarthritis: Implementation of precision medicine – Or “one size fits all” concept?
2024-9-1
Editorial Board
2024-9-1
Global incidence trends of autoimmune diseases from 1990 to 2021 and projections to 2050: A systemic analysis of the global burden of disease study 2021
2024-9-1
Janus kinase inhibitors in rheumatoid arthritis-associated interstitial lung disease: A systematic review and meta-analysis
2024-9-1
The intervention of macrophages in progressive fibrosis characterizing systemic sclerosis: A systematic review
2024-9-1
TO SHOw how we have been ENgaged in the APS FiELD (What we learned on APS collaborating with Professor Yehuda Shoenfeld)
2024-8-1
Cardiovascular disease in connective tissue disease-associated interstitial lung disease: A systematic review and meta-analysis of observational studies
2024-8-1
The effects of lifestyle interventions on disease activity and quality of life in patients with systemic lupus erythematosus: A systematic review
2024-8-1
Ear abnormalities in chronic fatigue syndrome (CFS), fibromyalgia (FM), Coronavirus-19 infectious disease (COVID) and long-COVID syndrome (PCS), sick-building syndrome (SBS), post-orthostatic tachycardia syndrome (PoTS), and autoimmune/inflammatory syndrome induced by adjuvants (ASIA): A systematic review
2024-8-1
Are the new 2023 ACR/EULAR classification criteria suitable for advancing the knowledge of obstetric antiphospholipid syndrome?
2024-8-1
The role of microbiota and oxidative stress axis and the impact of intravenous immunoglobulin in systemic lupus erythematosus
2024-8-1
Issues in autoantibody tests used in the classification criteria for autoimmune rheumatic diseases: the laboratory autoimmunologist's perspective
2024-8-1
B and T cells: (Still) the dominant orchestrators in autoimmune hepatitis
2024-8-1
Auto-immuno-deficiency syndromes
2024-8-1
Early skeletal muscle manifestations in polyarteritis nodosa and ANCA-associated vasculitis
2024-8-1
Navigating the landscape of SLE treatment: An expert viewpoint on the rationality and limitations of early biologic intervention
2024-8-1
Polymyalgia rheumatica and giant cell arteritis induced by immune checkpoint inhibitors: A systematic literature review highlighting differences from the idiopathic forms
2024-8-1
Predicting autoimmune diseases: A comprehensive review of classic biomarkers and advances in artificial intelligence
2024-8-1
Helminth derivative tuftsin-phopshorylcholine, to treat autoimmunity
2024-8-1
Reflecting on a decade of the international consensus on ANA patterns (ICAP): Accomplishments and challenges from the perspective of the 7th ICAP workshop
2024-8-1
Immune thrombocytopenia (ITP) - could it be part of autoimmune/inflammatory syndrome induced by adjuvants (ASIA)?
2024-8-1
Unraveling the global burden of inflammatory bowel disease (1990–2019): A Joinpoint regression analysis of divergent trends in 10–24 and 50–69 age cohorts
2024-7-1
Global prevalence of obesity in patients with psoriasis: An analysis in the past two decades
2024-7-1
The pipeline of immunomodulatory therapies in polymyalgia rheumatica and giant cell arteritis: A systematic review of clinical trials
2024-7-1
Relapses in giant cell arteritis: Updated review for clinical practice
2024-7-1
Amphibole asbestos as an environmental trigger for systemic autoimmune diseases
2024-7-1
Rituximab-induced cystoid macular edema in a patient with systemic lupus erythematosus: A case report and literature review
2024-7-1
Research Progress in pathogenesis of connective tissue disease-associated interstitial lung disease from the perspective of pulmonary cells
2024-7-1
Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus
2024-7-1
Editorial Board
2024-7-1
The role of mitochondrial dysfunction in kidney injury and disease
2024-6-1
Efferocytosis: Unveiling its potential in autoimmune disease and treatment strategies
2024-6-1
Cardiovascular and cerebrovascular outcomes in anti-neutrophil cytoplasmic antibody-associated vasculitis: A systematic review with meta-analysis
2024-6-1
Practical guidance for the early recognition and follow-up of patients with connective tissue diseaserelated interstitial lung disease
2024-6-1
Metabolic heterogeneity in tumor microenvironment – A novel landmark for immunotherapy
2024-6-1
Remodeling of T-cell mitochondrial metabolism to treat autoimmune diseases
2024-6-1
Biological markers of high risk of thrombotic recurrence in patients with antiphospholipid syndrome: A literature review
2024-6-1
Exposome: Epigenetics and autoimmune diseases
2024-6-1
Current evidence on the role of fibroblasts in large-vessel vasculitides: From pathogenesis to therapeutics
2024-6-1
Editorial Board
2024-6-1
Factors associated with incident cardiovascular disease in patients with rheumatoid arthritis: A scoping review
2024-5-1
Prevalence of anti-Ro52-kDa/SSA (TRIM21) antibodies and associated clinical phenotype in systemic sclerosis: Data from a French cohort, a systematic review and meta-analysis
2024-5-1
Twenty shades of the mosaic of autoimmunity
2024-5-1
The management of patients with inflammatory bowel disease-associated spondyloarthritis: Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Society of Rheumatology (SIR) recommendations based on a pseudo-Delphi consensus
2024-5-1
Inhibitors of Bruton's tyrosine kinase as emerging therapeutic strategy in autoimmune diseases
2024-5-1
From autoantibody test results to decision making: Incorporating likelihood ratios within medical practice
2024-5-1
What have we learned on pre, very early, and early systemic sclerosis microcirculatory pathophysiology? A scoping review
2024-5-1
Editorial Board
2024-5-1
帮你贴心管理全部的文献
研飞ivySCI,高效的论文管理
投稿经验分享
分享我的经验,帮你走得更远